Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists

Background The coronavirus disease 2019 (COVID-19) pandemic has overwhelmed the health systems worldwide. Data regarding the impact of COVID-19 on cancer patients (CPs) undergoing or candidate for immune checkpoint inhibitors (ICIs) are lacking. We depicted the practice and adaptations in the manage...

Full description

Bibliographic Details
Main Authors: Dario Trapani, Margaret Ottaviano, Pasquale Rescigno, Marianna Tortora, Giovannella Palmieri, Michele Aieta, Pasquale Assalone, Laura Attademo, Francesco Bloise, Davide Bosso, Valentina Borzillo, Giuseppe Buono, Giuseppe Calderoni, Francesca Caputo, Diletta Cavallero, Alessia Cavo, Raffaele Conca, Vincenza Conteduca, Stefano De Falco, Marco De Felice, Michelino De Laurentiis, Pietro De Placido, Irene De Santo, Alfonso De Stefano, Rossella Di Franco, Vincenzo Di Lauro, Antonietta Fabbrocini, Piera Federico, Pasqualina Giordano, Mario Giuliano, Antonella Lucia Marretta, Alessia Mennitto, Sara Merler, Valeria Merz, Carlo Messina, Monica Milano, Alessandro Marco Minisini, Brigitta Mucci, Lucia Nappi, Fabiana Napolitano, Immacolata Paciolla, Martina Pagliuca, Sara Parola, Angelica Petrillo, Francovito Piantedosi, Fernanda Picozzi, Erica Pietroluongo, Veronica Prati, Vittorio Riccio, Mario Rosanova, Alice Rossi, Anna Russo, Giuseppe Santabarbara, Antonia Silvestri, Massimiliano Spada, Paolo Tarantino, Paola Taveggia, Federica Tomei, Tortora Vincenzo, Claudia Trojanello, Sabrina Vari, Jole Ventriglia, Fabiana Vitiello, Caterina Vivaldi, Claudia von Arx, Francesca Zacchi, Ilaria Zampiva, Andrea Zivi
Format: Article
Language:English
Published: BMJ Publishing Group 2020-07-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/8/2/e001154.full